Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Teva Pharmaceutical Industries Limited (TEVA)

11.04   -0.5 (-4.33%) 05-23 16:01
Open: 11.82 Pre. Close: 11.86
High: 11.98 Low: 10.97
Volume: 15,080,569 Market Cap: 12061M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 11.474 - 11.545 11.545 - 11.596
Low: 10.803 - 10.891 10.891 - 10.953
Close: 10.925 - 11.053 11.053 - 11.144

Technical analysis

as of: 2019-05-23 4:28:42 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 16.24     One year: 18.36
Support: Support1: 10.97    Support2: 9.13
Resistance: Resistance1: 13.91    Resistance2: 15.72
Pivot: 12.86
Moving Average: MA(5): 11.51     MA(20): 13.46
MA(100): 16.27     MA(250): 19.78
MACD: MACD(12,26): -1.04     Signal(9): -0.84
Stochastic oscillator: %K(14,3): 7.61     %D(3): 8.57
RSI: RSI(14): 22.75
52-week: High: 25.96  Low: 10.97  Change(%): -49.0
Average Vol(K): 3-Month: 1247504  10-Days: 2066054

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
TEVA has closed above bottom band by 20.2%. Bollinger Bands are 109.1% wider than normal. The large width of the bands suggest high volatility as compared to TEVA's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.

Headline News

Wed, 22 May 2019 14:08:48 Z
Better Turnaround Play: Bausch Health Companies or Teva Pharmaceutical Industries

Mon, 20 May 2019 20:06:15 Z
Credit Suisse Absolutely Is Right to Double Down on Pfizer Stock

Mon, 20 May 2019 13:06:51 Z
We Did The Math PPH Can Go To $70

Fri, 17 May 2019 23:11:01 Z
Roche Gets FDA Nod for Venclexta Plus Gazyva to Treat CLL

Wed, 15 May 2019 15:14:18 Z
The Zacks Analyst Blog Highlights: Teva, Mylan, Novartis and Pfizer

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 1092.46
Shares Float (M) 1089.98
% Held by Insiders
% Held by Institutions 91.90
Shares Short (K) 18178
Shares Short P. Month (K)

Stock Financials

EPS 2.850
EPS Est. Current Year 4.230
EPS Est. Next Year 3.690
EPS Est. Next Quarter 1.090
Forward EPS 2.790
Book Value (p.s.) 0.850
PEG Ratio -1.64
Profit Margin -21.13
Operating Margin 14.85
Return on Assets (ttm) -5.8
Return on Equity (ttm) -25.1
Qtrly Rev. Growth -15.2
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) 1060.00
Levered Free Cash Flow (M) 1900.00

Stock Valuations

P/E 3.87
P/E Growth Ratio -0.04
P/BV 12.99
P/S 691586176.00
P/CF 11.38

Dividends & Splits

Dividend Yield
Dividend Pay Date 2017-12-12
Ex-Dividend Date 2017-11-27
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.